Clinical Trials Logo

Filter by:
NCT ID: NCT00322595 Completed - Clinical trials for Generalized Anxiety Disorder

Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder

SILVER
Start date: May 2006
Phase: Phase 3
Study type: Interventional

The primary purpose of this study is to evaluate the efficacy of (SEROQUEL SR™ ) quetiapine fumarate sustained-release (SR) compared to placebo in the treatment of anxiety symptoms in patients with generalized anxiety disorder (GAD). PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

NCT ID: NCT00322218 Terminated - Clinical trials for Lymphoma, Large Cell, Diffuse

Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.

Start date: May 2006
Phase: Phase 3
Study type: Interventional

This study treats patients with diffuse large B-cell lymphoma whose disease is in complete remission due to previous treatment with Cyclophosphamide Doxorubicin hydrochloride Vincristine Prednisolone- Rituximab (CHOP-R). Half of the patients received Zevalin and the other half receive no further anti-cancer treatment. The two patient groups compared to determine if Zevalin given after CHOP-R therapy provides greater benefits than receiving no additional anti-cancer therapy after CHOP-R.

NCT ID: NCT00322036 Terminated - Alzheimer Disease Clinical Trials

Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

Start date: May 2006
Phase: Phase 3
Study type: Interventional

This is a multinational, randomized, double blind, placebo controlled, parallel group study comparing the safety and efficacy of daily dosing of 800 mg twice daily MPC-7869 to placebo. Study subjects will have the diagnosis of mild dementia of the Alzheimer's type. Subjects may be taking approved medication for Alzheimer's disease provided the dose has been stable for at least 6 months.

NCT ID: NCT00321919 Completed - Anemia Clinical Trials

A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia

Start date: July 2000
Phase: Phase 3
Study type: Interventional

This study will evaluate whether anemia prevention with NeoRecormon has an additional impact on reducing cardiovascular risk over conventional anemia treatment in patients mostly with stage IV chronic kidney disease and renal anemia. The anticipated time on study treatment is 2+ years and the target sample size is 500+ individuals.

NCT ID: NCT00321854 Completed - Parkinson Disease Clinical Trials

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

Start date: May 2006
Phase: Phase 4
Study type: Interventional

This is a double blind, placebo-controlled clinical trial of 15 months duration designed to examine early Mirapex (pramipexole) treatment vs. delayed Mirapex (pramipexole) treatment in patients with new onset Parkinsons disease

NCT ID: NCT00321633 Completed - Breast Cancer Clinical Trials

Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer

Start date: September 2005
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as carboplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether carboplatin is more effective than docetaxel in treating patients with metastatic genetic breast cancer. PURPOSE: This randomized phase II trial is studying carboplatin to see how well it works compared to docetaxel in treating women with metastatic genetic breast cancer.

NCT ID: NCT00320450 Completed - Clinical trials for Arthritis, Rheumatoid

SB-681323 In Subjects With Rheumatoid Arthritis

Start date: November 2005
Phase: Phase 2
Study type: Interventional

The purpose of this research is to find out how effective and safe SB-681323 will be in the treatment of RA when it is added to standard anti-rheumatic treatments.

NCT ID: NCT00320190 Terminated - Clinical trials for Leukemia, Myeloid, Chronic

Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib

Start date: August 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the efficacy of dasatinib with that of high-dose (800-mg) imatinib in participants with chronic phase chronic myeloid leukemia who achieved only a suboptimal response after at least 3 months of monotherapy with 400-mg imatinib. The safety of these treatments will also be evaluated.

NCT ID: NCT00319098 Completed - Influenza Clinical Trials

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above

Start date: May 1, 2006
Phase: Phase 3
Study type: Interventional

Today, the leading contender for the next pandemic of influenza is H5N1, a strain of avian virus. Prevention and control will depend on the rapid production and worldwide distribution of specific pandemic vaccines. Candidate 'pandemic-like' vaccines must be developed and tested in clinical trials to determine the most optimal formulation and the best vaccination schedule. This study is designed to test in healthy adults aged above 18 years the reactogenicity and immunogenicity of one and two administrations of a candidate pandemic H5N1 vaccine formulated from Split Virus.

NCT ID: NCT00319033 Completed - Clinical trials for Interstitial Lung Disease

Open-label Study With Bosentan in Interstitial Lung Disease

BUILD 2 OL
Start date: July 2004
Phase: Phase 2/Phase 3
Study type: Interventional

This study will asses the long term safety and efficacy of oral bosentan to patients suffering from Interstitial Lung Disease.